Xeris Biopharma Holdings (XERS) Shares Outstanding (Diluted) (2021 - 2026)
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 1.23 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | 210.89 Mn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 208.22 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 45.80 Mn |
| 10 | Xeris Biopharma Holdings | 1.39 Bn | 1.27 Bn | 79.59 Mn | 172.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 172.82 Mn |
| Mar 31, 2026 | 177.63 Mn |
| Dec 31, 2025 | 172.74 Mn |
| Sep 30, 2025 | 177.62 Mn |
| Jun 30, 2025 | 159.46 Mn |
| Mar 31, 2025 | 152.45 Mn |
| Dec 31, 2024 | 146.77 Mn |
| Sep 30, 2024 | 148.99 Mn |
| Jun 30, 2024 | 148.35 Mn |
| Mar 31, 2024 | 140.51 Mn |
| Dec 31, 2023 | 137.67 Mn |
| Sep 30, 2023 | 138.06 Mn |
| Jun 30, 2023 | 137.34 Mn |
| Mar 31, 2023 | 137.14 Mn |
| Dec 31, 2022 | 135.63 Mn |
| Sep 30, 2022 | 135.95 Mn |
| Jun 30, 2022 | 135.53 Mn |
| Mar 31, 2022 | 135.03 Mn |
| Dec 31, 2021 | 79.03 Mn |
| Sep 30, 2021 | 66.50 Mn |